
Lipoprotein-associated phospholipase A2 levels as a predictor of cardiovascular risks in patients with COPD and obstructive sleep apnea
Keywords: COPD, chronic obstructive lung disease; OSA, obstructive sleep apnea; Lp-PLA2, lipoprotein-associated phospholipase A2; PSG, polysomnography; AHI, apnea-hypopnea index; FEV1, forced expiratory volume in the first second; EVC, forced vital capacity; ESS, E